Nelleke A. Gruis

14.5k citations

103 papers · 6.5k indexed · 1 hit paper · h-index 36

Oncology top 0.5%
- Cutaneous Melanoma Detection and Management 49
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 28
Dermatology top 0.5%
- Skin Protection and Aging 12
Cell Biology top 1%
- melanin and skin pigmentation 17
Ophthalmology top 1%
- Ocular Oncology and Treatments 12
Molecular Biology
- Melanoma and MAPK Pathways 16
- Epigenetics and DNA Methylation 14
Immunology
- Immunotherapy and Immune Responses 11

Co-authors: Jane Weaver-Feldhaus Alexander Kamb Pieter A. van der Velden Mark H. Skolnick Qingyun Liu Elisabeth Stockert Rufus S. Day Bruce E. Johnson
Cited by: Oncology Cancer Research Dermatology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Nelleke A. Gruis

102 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Nelleke A. Gruis

Since Specialization

Citations

This map shows the geographic impact of Nelleke A. Gruis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelleke A. Gruis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelleke A. Gruis more than expected).

Fields of papers citing papers by Nelleke A. Gruis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelleke A. Gruis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelleke A. Gruis. The network helps show where Nelleke A. Gruis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nelleke A. Gruis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nelleke A. Gruis Line = papers co-authored together Nelleke A. Gruis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The importance of motivation in selecting undergraduate medical students for extracurricular research programmes Belinda W. C. Ommering,Floris M. van Blankenstein,Merel van Diepen,Nelleke A. Gruis,Ada Kool,Friedo W. Dekker	2021	0
2	Accurate Quantification of T Cells in Copy Number Stable and Unstable DNA Samples Using Multiplex Digital PCR Rogier J. Nell,Willem H. Zoutman,Neus Calbet‐Llopart,Adriana García‐Herrera,Nino V. Menger,Mieke Versluis,Susana Puig,Nelleke A. Gruis,Pieter A. van der Velden	2021	3
3	Genome‐wide characterization of 5‐hydoxymethylcytosine in melanoma reveals major differences with nevus Catarina Salgado,Jan Oosting,Bart Janssen,Rajiv Kumar,Nelleke A. Gruis,Remco van Doorn	2020	8
4	Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression Catarina Salgado,Celine M. Roelse,Rogier J. Nell,Nelleke A. Gruis,Remco van Doorn,Pieter van der Velden	2020	17
5	Association of HERV-K and LINE-1 Hypomethylation with Reduced Disease-Free Survival in Melanoma Patients Maurizio Cardelli,Remco van Doorn,Lares Larcher,Michela Di Donato,Francesco Piacenza,Elisa Pierpaoli,Robertina Giacconi,Marco Malavolta,P. Sivaramakrishna Rachakonda,Nelleke A. Gruis,Anders Molven,Per Arne Andresen,Dace Pjanova,Joost J. van den Oord,Mauro Provinciali,Eduardo Nagore,Rajiv Kumar	2020	13
6	Genome-wide analysis of constitutional DNA methylation in familial melanoma Catarina Salgado,Nelleke A. Gruis,Bastiaan T. Heijmans,Jan Oosting,Remco van Doorn	2020	4
7	Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013–2018) Mijke Visser,Nienke van der Stoep,Nelleke A. Gruis	2019	5
8	<em>MC1R</em> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project Elena Tagliabue,Sara Gandini,Rino Bellocco,Patrick Maisonneuve,Julia Newton‐Bishop,David Polsky,DeAnn Lazovich,Peter A. Kanetsky,Paola Ghiorzo,Nelleke A. Gruis,Maria Teresa Landi,Chiara Menin,Maria Concetta Fargnoli,José C. García‐Borrón,Jiali Han,Julian Little,Francesco Sera,Sara Raimondi	2018	57
9	Genomic analysis and clinical management of adolescent cutaneous melanoma Roy Rabbie,Mamunur Rashid,Ana Arance,Marcelo Sánchez,Gemma Tell‐Martí,Míriam Potrony,Carles Conill,Remco van Doorn,Stefan C. Dentro,Nelleke A. Gruis,Pippa Corrie,Vivek Iyer,Carla Daniela Robles‐Espinoza,Joan Anton Puig‐Butillé,Susana Puig,David J. Adams	2017	10
10	Germline TERT promoter mutations are rare in familial melanoma Mark Harland,Mia Petljak,Carla Daniela Robles‐Espinoza,Zhihao Ding,Nelleke A. Gruis,Remco van Doorn,Karen A. Pooley,Alison M. Dunning,Lauren G. Aoude,Karin Wadt,Anne‐Marie Gerdes,Kevin M. Brown,Nicholas K. Hayward,Julia Newton‐Bishop,David J. Adams,D. Timothy Bishop	2015	43
11	Promoter CpG Island Hypermethylation in Dysplastic Nevus and Melanoma: CLDN11 as an Epigenetic Biomarker for Malignancy Linda Gao,Karin van den Hurk,Peter T.M. Moerkerk,Jelle J. Goeman,Samuel J. Beck,Nelleke A. Gruis,Joost J. van den Oord,Véronique Winnepenninckx,Manon van Engeland,Remco van Doorn	2014	37
12	Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma Linda Gao,Marjon A. Smit,Joost J. van den Oord,Jelle J. Goeman,Els M.E. Verdegaal,Sjoerd H. van der Burg,Marguerite Stas,Samuel J. Beck,Nelleke A. Gruis,Cornelis P. Tensen,Rein Willemze,Daniel S. Peeper,Remco van Doorn	2013	49
13	Melanocortin 1 Receptor (MC1R) Variants in High Melanoma Risk Patients are Associated with Specific Dermoscopic ABCD Features Koen D. Quint,June‐Wha Rhee,Nelleke A. Gruis,Jeanet ter Huurne,Ron Wolterbeek,Nienke van der Stoep,W. Bergman,Nicole A. Kukutsch	2012	18
14	A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds Julie Lang,Michael Shennan,Jenny C.-N. Njauw,Su Luo,Julia Newton‐Bishop,Mark Harland,Nicholas K. Hayward,Margaret A. Tucker,Alisa M. Goldstein,Maria Teresa Landi,Susana Puig,Nelleke A. Gruis,Wilma Bergman,Giovanna Bianchi‐Scarrà,Paola Ghiorzo,David Hogg,Hensin Tsao	2010	10
15	From sporadic atypical nevi to familial melanoma: Risk analysis for melanoma in sporadic atypical nevus patients Femke A. de Snoo,Marije W. Kroon,Wilma Bergman,Jeanet A.C. ter Huurne,Jeanine J. Houwing‐Duistermaat,Leny van Mourik,Dyon G.C.T.M. Snels,Martijn H. Breuning,Rein Willemze,Rune R. Frants,Nelleke A. Gruis	2007	10
16	Aberrant DNA Methylation in Cutaneous Malignancies Remco van Doorn,Nelleke A. Gruis,Rein Willemze,Pieter A. van der Velden,Cornelis P. Tensen	2005	50
17	Melanocortin-1 Receptor Gene Variants Determine the Risk of Nonmelanoma Skin Cancer Independently of Fair Skin and Red Hair Maarten T. Bastiaens,Jeannet A. C. ter Huurne,Christine J. Kielich,Nelleke A. Gruis,Rudi G. J. Westendorp,B.J. Vermeer,Jan Nico Bouwes Bavinck	2001	193
18	オランダの家族性異型多発母斑黒色腫(FAMMM)症候群の家族における黒色腫のリスクを変化させるP16にリンクされた遺伝子座 Van Der Velden P A,L. Sandkuijl,W. Bergman,Einar Hille,R.R. Frants,Nelleke A. Gruis	1999	2
19	A Locus Linked to p16 Modifies Melanoma Risk in Dutch Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome Families Pieter A. van der Velden,Lodewijk A. Sandkuijl,Wilma Bergman,E.T.M. Hille,Rune R. Frants,Nelleke A. Gruis	1999	14
20	Common 9p haplotype in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families; no evidence for involvement of MTS1 Nelleke A. Gruis,Lodewijk A. Sandkuijl,Mark H. Skolnick	1994	2

About Nelleke A. Gruis

Nelleke A. Gruis is a scholar working on Oncology, Cancer Research and Dermatology, having authored 103 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (49 papers), Cancer Genomics and Diagnostics (28 papers), melanin and skin pigmentation (17 papers), Melanoma and MAPK Pathways (16 papers), Epigenetics and DNA Methylation (14 papers), Skin Protection and Aging (12 papers), Ocular Oncology and Treatments (12 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.7k citations) and Dermatology (691 citations). Nelleke A. Gruis has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jane Weaver-Feldhaus, Alexander Kamb, Pieter A. van der Velden, Mark H. Skolnick, Qingyun Liu, Elisabeth Stockert, Rufus S. Day, Bruce E. Johnson, Keith Harshman and Sean V. Tavtigian.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact